← Back to Search

Behavioral Intervention

A Single arm study to evaluate the effectiveness of Hola Bebe application for Gestational Diabetes

N/A
Waitlist Available
Led By Dharma Cortes
Research Sponsored by Environment and Health Group, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 month
Awards & highlights

Study Summary

This trial will test whether the Hola Bebe intervention can help Hispanic women with recent GDM to improve self-efficacy for healthy eating and physical activity, and to lose weight.

Eligible Conditions
  • Gestational Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sallis Self Efficacy for Healthy Eating
Sallis Self Efficacy for Physical Activity
Secondary outcome measures
Weight loss
Other outcome measures
HbA1C level

Trial Design

1Treatment groups
Experimental Treatment
Group I: A Single arm study to evaluate the effectiveness of Hola Bebe applicationExperimental Treatment1 Intervention
Participants will receive the handout "It's never too early to prevent diabetes" and will meet with the health educator at their CHC and download the Hola Bebe app. The health educator will advise participants to watch one module and complete an action plan for each of the first 12 weeks of study and encourage participants to weigh themselves weekly. The app includes the following features:1) educational/ behavioral audio visual modules, with automatic prompting to complete an action plan at the end of each module; 2) a motivational message library so that participants can chose which motivational texts they wish to receive, how often and time of day; 3) a community forum where participants can interact with each other and ask questions to the health educator; 4) tracking of weights to allow participants to see a graphic of their weight over time by inputting weekly weights; and 5) awards program where participants can earn badges for completing modules.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hola Bebe
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Environment and Health Group, Inc.Lead Sponsor
7 Previous Clinical Trials
762 Total Patients Enrolled
Dharma CortesPrincipal InvestigatorEnvironment and Health Group, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to partake in this clinical research?

"Aspiring participants of this medical study should have a diagnosis of gestational diabetes mellitus and fall between 18 to 45 years old. The trial is currently recruiting approximately 150 individuals."

Answered by AI

Are there any available openings for participants in this medical experiment?

"Affirmative. According to clinicaltrials.gov, this study is actively enrolling patients since its initial posting in February 2020 and latest update on August 3rd 2022. 150 applicants are needed at two separate medical centres."

Answered by AI

Are adults of eighteen years or older eligible to participate in the trial?

"This clinical trial requires that potential participants be aged between 18 and 45 years old."

Answered by AI

How many participants is this empirical research involving?

"This is accurate. As found on clinicaltrials.gov, this research study was initially published in February of 2020 and last updated in August 2022. In order to obtain the desired results, 150 participants must be enrolled at two trial centers."

Answered by AI
~15 spots leftby Apr 2025